Rubric Capital Management LP 13D and 13G filings for Sutro Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 4:30 pm Sale | 2024-09-30 | 13G | Sutro Biopharma, Inc. STRO | Rubric Capital Management LP | 0 0.000% | -3,344,810 (Position Closed) | Filing |
| 2024-02-12 06:06 am Purchase | 2023-12-31 | 13G | Sutro Biopharma, Inc. STRO | Rubric Capital Management LP | 3,344,810 5.490% | 132,938 (+4.14%) | Filing |
| 2023-02-10 4:00 pm Purchase | 2022-12-31 | 13G | Sutro Biopharma, Inc. STRO | Rubric Capital Management LP | 3,211,872 5.590% | 3,211,872 (New Position) | Filing |